Gene Young Cho1,2, Linda Moy3,4, Sungheon G Kim3,4, Steven H Baete3,4, Melanie Moccaldi5, James S Babb3,4, Daniel K Sodickson3,4, Eric E Sigmund3,4. 1. Center for Advanced Imaging Innovation and Research (CAI2R), New York University School of Medicine, 660 First Ave. 4th Floor, New York City, NY, 10016, USA. gyc219@nyumc.org. 2. Bernard and Irene Schwartz Center for Biomedical Imaging, Department of Radiology, New York University School of Medicine, New York, NY, 10016, USA. gyc219@nyumc.org. 3. Center for Advanced Imaging Innovation and Research (CAI2R), New York University School of Medicine, 660 First Ave. 4th Floor, New York City, NY, 10016, USA. 4. Bernard and Irene Schwartz Center for Biomedical Imaging, Department of Radiology, New York University School of Medicine, New York, NY, 10016, USA. 5. New York University Langone Medical Center - Cancer Institute, New York, NY, 10016, USA.
Abstract
PURPOSE: To examine heterogeneous breast cancer through intravoxel incoherent motion (IVIM) histogram analysis. MATERIALS AND METHODS: This HIPAA-compliant, IRB-approved retrospective study included 62 patients (age 48.44 ± 11.14 years, 50 malignant lesions and 12 benign) who underwent contrast-enhanced 3 T breast MRI and diffusion-weighted imaging. Apparent diffusion coefficient (ADC) and IVIM biomarkers of tissue diffusivity (Dt), perfusion fraction (fp), and pseudo-diffusivity (Dp) were calculated using voxel-based analysis for the whole lesion volume. Histogram analysis was performed to quantify tumour heterogeneity. Comparisons were made using Mann-Whitney tests between benign/malignant status, histological subtype, and molecular prognostic factor status while Spearman's rank correlation was used to characterize the association between imaging biomarkers and prognostic factor expression. RESULTS: The average values of the ADC and IVIM biomarkers, Dt and fp, showed significant differences between benign and malignant lesions. Additional significant differences were found in the histogram parameters among tumour subtypes and molecular prognostic factor status. IVIM histogram metrics, particularly fp and Dp, showed significant correlation with hormonal factor expression. CONCLUSION: Advanced diffusion imaging biomarkers show relationships with molecular prognostic factors and breast cancer malignancy. This analysis reveals novel diagnostic metrics that may explain some of the observed variability in treatment response among breast cancer patients. KEY POINTS: • Novel IVIM biomarkers characterize heterogeneous breast cancer. • Histogram analysis enables quantification of tumour heterogeneity. • IVIM biomarkers show relationships with breast cancer malignancy and molecular prognostic factors.
PURPOSE: To examine heterogeneous breast cancer through intravoxel incoherent motion (IVIM) histogram analysis. MATERIALS AND METHODS: This HIPAA-compliant, IRB-approved retrospective study included 62 patients (age 48.44 ± 11.14 years, 50 malignant lesions and 12 benign) who underwent contrast-enhanced 3 T breast MRI and diffusion-weighted imaging. Apparent diffusion coefficient (ADC) and IVIM biomarkers of tissue diffusivity (Dt), perfusion fraction (fp), and pseudo-diffusivity (Dp) were calculated using voxel-based analysis for the whole lesion volume. Histogram analysis was performed to quantify tumour heterogeneity. Comparisons were made using Mann-Whitney tests between benign/malignant status, histological subtype, and molecular prognostic factor status while Spearman's rank correlation was used to characterize the association between imaging biomarkers and prognostic factor expression. RESULTS: The average values of the ADC and IVIM biomarkers, Dt and fp, showed significant differences between benign and malignant lesions. Additional significant differences were found in the histogram parameters among tumour subtypes and molecular prognostic factor status. IVIM histogram metrics, particularly fp and Dp, showed significant correlation with hormonal factor expression. CONCLUSION: Advanced diffusion imaging biomarkers show relationships with molecular prognostic factors and breast cancer malignancy. This analysis reveals novel diagnostic metrics that may explain some of the observed variability in treatment response among breast cancerpatients. KEY POINTS: • Novel IVIM biomarkers characterize heterogeneous breast cancer. • Histogram analysis enables quantification of tumour heterogeneity. • IVIM biomarkers show relationships with breast cancer malignancy and molecular prognostic factors.
Entities:
Keywords:
Breast MR; Breast cancer; Diffusion-weighted MRI; Intravoxel incoherent motion; Tumour heterogeneity
Authors: R Prevos; M L Smidt; V C G Tjan-Heijnen; M van Goethem; R G Beets-Tan; J E Wildberger; M B I Lobbes Journal: Eur Radiol Date: 2012-09-16 Impact factor: 5.315
Authors: Moti Freiman; Jeannette M Perez-Rossello; Michael J Callahan; Stephan D Voss; Kirsten Ecklund; Robert V Mulkern; Simon K Warfield Journal: Med Image Anal Date: 2013-01-03 Impact factor: 8.545
Authors: Katja Pinker; Linda Moy; Elizabeth J Sutton; Ritse M Mann; Michael Weber; Sunitha B Thakur; Maxine S Jochelson; Zsuzsanna Bago-Horvath; Elizabeth A Morris; Pascal At Baltzer; Thomas H Helbich Journal: Invest Radiol Date: 2018-10 Impact factor: 6.016
Authors: Oscar Jalnefjord; Mats Andersson; Mikael Montelius; Göran Starck; Anna-Karin Elf; Viktor Johanson; Johanna Svensson; Maria Ljungberg Journal: MAGMA Date: 2018-08-16 Impact factor: 2.310
Authors: Eddie Surer; Cristina Rossi; Anton S Becker; Tim Finkenstaedt; Moritz C Wurnig; Antonios Valavanis; Sebastian Winklhofer Journal: Neuroradiology Date: 2018-02-22 Impact factor: 2.804
Authors: D Leithner; G J Wengert; T H Helbich; S Thakur; R E Ochoa-Albiztegui; E A Morris; K Pinker Journal: Clin Radiol Date: 2017-12-09 Impact factor: 2.350
Authors: Jason Ostenson; Akshat C Pujara; Artem Mikheev; Linda Moy; Sungheon G Kim; Amy N Melsaether; Komal Jhaveri; Sylvia Adams; David Faul; Christopher Glielmi; Christian Geppert; Thorsten Feiweier; Kimberly Jackson; Gene Y Cho; Fernando E Boada; Eric E Sigmund Journal: Magn Reson Med Date: 2016-10-25 Impact factor: 4.668